Walder Wyss has advised ista as buyer; valfor has advised the shareholders of Blockstrom AG. Blockstrom AG, a company recognized for its pioneering work in digital...
Blockstrom AG Acquired by ista Swiss AG to Enhance Integrated Building Energy Solutions
Mosanna Therapeutics Completes USD 80 Million Series A Funding Round
VISCHER has advised Mosanna Therapeutics AG; Walder Wyss advised EQT Life Sciences. Mosanna Therapeutics AG has successfully closed its USD 80 million Series A funding round....
RhyGaze AG’s $86 Million Series A Financing Round
Walder Wyss advised RhyGaze AG on the deal. RhyGaze, a biotechnology company based in Basel and Philadelphia has secured a Series A financing of USD 86...
Boehringer Ingelheim’s CHF450 Million Acquisition of T3 Pharmaceuticals AG
Walder Wyss advised Boehringer Ingelheim in the transaction. Boehringer Ingelheim announced the acquisition of privately-held T3 Pharmaceuticals AG, a clinical stage Swiss biotech company, for an...
Nouscom’s €67.5 Million Oversuscribed Series C Financing Round
Walder Wyss advised the investors while VISCHER acted as legal advisor to Nouscom in the transaction. Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized...